- Home
- MOVE vs EVMN Comparison
MOVE vs EVMN Comparison
Compare MOVE & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOVE | EVMN |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.4M | 241.3M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | MOVE | EVMN |
|---|---|---|
| Price | $9.81 | $6.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $24.13 |
| AVG Volume (30 Days) | 141.4K | ★ 911.3K |
| Earning Date | 11-13-2026 | 11-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 75.23 |
| EPS | N/A | ★ N/A |
| Revenue | $433,000.00 | ★ $13,000,000.00 |
| Revenue This Year | $119.80 | N/A |
| Revenue Next Year | $1,179.59 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $4.67 | $6.08 |
| 52 Week High | $34.87 | $33.20 |
Technical Indicators
Market Signals| Indicator | MOVE | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 38.55 | 19.23 |
| Support Level | $8.60 | N/A |
| Resistance Level | $15.83 | $13.35 |
| Average True Range (ATR) | 0.83 | 0.56 |
| MACD | -0.15 | -0.16 |
| Stochastic Oscillator | 6.22 | 8.84 |
Price Performance
Historical ComparisonAbout MOVE Movano Inc.
Corvex Inc is an AI cloud computing company that provides computing infrastructure for artificial intelligence workloads, including GPU-accelerated computing, confidential computing, and inference services. Its offerings are used by government and enterprise customers, including those with regulated workloads, to support the deployment and operation of AI models and data processing systems. The company generates revenue from the sale of Wellness Rings, portable chargers and charging cables, ring sizers, and mobile applications.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.